FDA Clears New Blood Test that Could Speed Alzheimer’s Diagnosis and Treatment

Health & LifestyleNews
146

Listen to article (english)

Translate to Spanish or other 102 languages!

With Alzheimer’s rates climbing and diagnoses often delayed until symptoms progress, a new FDA-cleared blood test could mark a turning point in how the disease is identified and managed. Image for illustration purposes
With Alzheimer’s rates climbing and diagnoses often delayed until symptoms progress, a new FDA-cleared blood test could mark a turning point in how the disease is identified and managed. Image for illustration purposes

Mega Doctor News

- Advertisement -

By George Washington University

Newswise – With Alzheimer’s rates climbing and diagnoses often delayed until symptoms progress, a new FDA-cleared blood test could mark a turning point in how the disease is identified and managed.

This week, the FDA cleared Roche’s Elecsys pTau181 test — only the second blood-based biomarker test approved this year for Alzheimer’s disease. The test, developed with Eli Lilly, gives primary care physicians a faster way to help rule out Alzheimer’s in patients showing signs of cognitive decline, potentially reducing reliance on costly PET scans and getting patients to answers — and treatment — sooner.

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
HHSC Encourages Preventive Care During Breast Cancer Awareness Month
Next article
STHS Children’s Partners with Spirit Halloween for Pre-Halloween Party for Patients

More Articles

Rural Texas Healthcare Boosted by $8 Million in New Grants

Governor Greg Abbott announced that the Texas Health and Human Services Commission (HHSC) plans to award $8 million in Rural Texas Strong grants to 28 rural healthcare providers throughout the state.

Study Links Excessive Pregnancy Weight Gain to Severe Maternal Risks

A new study of more than one million births led by McMaster University researchers has found that gaining too much weight during pregnancy, regardless of a person’s starting weight, is linked to a higher risk of life-threatening maternal complications.

Second NISOD Award Recognized for STC Pharmacy Technology Teaching

 For nearly two decades, South Texas College (STC) faculty member and Department Chair Theresa Garza, Pharm.D., has helped shape the college's Pharmacy Technology program, bringing real-world pharmacy experience into the classroom and expanding hands-on training opportunities that prepare students for careers in healthcare.

STHS Children’s Shares Halloween Safety Tips

Halloween may be known for its tricks and treats, but amid the excitement of the holiday, potential hazards can quickly turn a night of fun into an unexpected trip to the emergency room.
- Advertisement -